sub6manletnozygos
Kraken
- Joined
- Nov 19, 2019
- Posts
- 4,167
- Reputation
- 6,278
For the purpose of this thread, I am only talking about laser irdoplasty (laser that destroys melonin in the eye, revealing pigments below that give the appearance of 'grey'/'blue' eyes), not any keratopigmentation (inserted pigment which has a noticeably higher adverse outcomes and looks unnatural).
The two laser clinics I have identified are Eyecos in Barcelona and Yeux Clairs in Monterrey.
Outcomes with latest technology seem ok, with low rates of raised intra ocular pressure and no sustained glaucoma, according to 1 study (it has a conflict of interest with eyecos). What is amusing is that the paper notes inadvertent improvements in myopia due to refractive corrections. This is interesting as I have slight myopia.
Unfortunately, the study has limited data, and only records results from 2017-2020. It would be interesting to see long term follow ups 3-30+ years.
There is Stroma, which is incorporated in America, and is currently being trialed, but is not approved by the FDA for consumer consumption yet.
The two laser clinics I have identified are Eyecos in Barcelona and Yeux Clairs in Monterrey.
Outcomes with latest technology seem ok, with low rates of raised intra ocular pressure and no sustained glaucoma, according to 1 study (it has a conflict of interest with eyecos). What is amusing is that the paper notes inadvertent improvements in myopia due to refractive corrections. This is interesting as I have slight myopia.
Some myopic patients became emmetropic and, proportionally, several emmetropes became slightly hyperopic and presbyopic. For practical purposes, this change in refractive errors meant many patients with slight accommodative myopia no longer needed glasses or contact lenses, since their distance vision was ostensibly improved.
Photoablative cosmetic iridoplasty: effective, safe, and predictable—eye color change in 1176 eyes - PMC
To evaluate photoablative cosmetic iridoplasty (PCI), and its efficacy, safety, predictability, and satisfaction with the 532 nm Crystal Q-switched Nd: Yag laser, with 3–4 ns pulses, for depigmentation of the anterior epithelium of the iris in cases ...
pmc.ncbi.nlm.nih.gov
Unfortunately, the study has limited data, and only records results from 2017-2020. It would be interesting to see long term follow ups 3-30+ years.
There is Stroma, which is incorporated in America, and is currently being trialed, but is not approved by the FDA for consumer consumption yet.
Last edited: